Drug news
NICE recommends Forxiga (dapagliflozin) with metformin and a sulfonylurea as triple therapy fro type 2 daibetes= AstarZeneca.
The National Institute for Health and Care Excellence (NICE) has recommended Forxiga (dapagliflozin) from AstraZeneca as part of a triple therapy treatment for Type 2 Diabetes which will include metformin and a sulfonylurea.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.